BrightSpring Health Services, Inc.
For the period ended Jun 30, 2025. Filed Aug 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 1, 2025
BTSG$69.15+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(In thousands, except per share amounts)
| For the Three Months Ended · For the Six Months Ended | ||||
|---|---|---|---|---|
| June 30, | June 30, | |||
| 2025 | 2024 | 2025 | 2024 | |
| Revenues: | ||||
| Products | $2,790,101 | $2,114,491 | $5,322,272 | $4,091,526 |
| Services | 357,597 | 323,763 | 703,555 | 632,494 |
| Total revenues | 3,147,698 | 2,438,254 | 6,025,827 | 4,724,020 |
| Cost of goods | 2,556,402 | 1,931,760 | 4,884,617 | 3,738,860 |
| Cost of services | 216,444 | 194,318 | 427,989 | 380,493 |
| Gross profit | 374,852 | 312,176 | 713,221 | 604,667 |
| Selling, general, and administrative expenses | 326,295 | 273,523 | 613,925 | 581,349 |
| Operating income | 48,557 | 38,653 | 99,296 | 23,318 |
| Loss on extinguishment of debt | — | — | — | 12,726 |
| Interest expense, net | 38,778 | 43,282 | 80,541 | 97,752 |
| Income (loss) from continuing operations before income taxes | 9,779 | (4,629) | 18,755 | (87,160) |
| Income tax expense (benefit) | 1,238 | (13,115) | 998 | (39,619) |
| Income (loss) from continuing operations, net of income taxes | 8,541 | 8,486 | 17,757 | (47,541) |
| Income from discontinued operations, net of income taxes | 19,001 | 10,955 | 38,795 | 20,597 |
| Net income (loss) | 27,542 | 19,441 | 56,552 | (26,944) |
| Net loss attributable to noncontrolling interests included in continuing operations | (666) | (478) | (1,198) | (1,113) |
| Net income (loss) attributable to BrightSpring Health Services, Inc. and subsidiaries | $28,208 | $19,919 | $57,750 | $(25,831) |
| Net income (loss) per common share (Note 10): | ||||
| Basic income (loss) per share attributable to common shareholders: | ||||
| Continuing operations | $0.05 | $0.05 | $0.09 | $(0.25) |
| Discontinued operations | $0.09 | $0.05 | $0.20 | $0.11 |
| Net income (loss) | $0.14 | $0.10 | $0.29 | $(0.14) |
| Diluted income (loss) per share attributable to common shareholders: | ||||
| Continuing operations | $0.04 | $0.04 | $0.09 | $(0.25) |
| Discontinued operations | $0.09 | $0.06 | $0.18 | $0.11 |
| Net income (loss) | $0.13 | $0.10 | $0.27 | $(0.14) |
| Weighted average shares outstanding: | ||||
| Basic | 201,807 | 197,515 | 200,516 | 186,523 |
| Diluted | 216,336 | 208,987 | 214,963 | 186,523 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.